ESC 365 - A placebo-controlled trial of percutaneous coronary intervention for stable angina: the ORBITA-2 trial

ESC Professional Premium Access

A placebo-controlled trial of percutaneous coronary intervention for stable angina: the ORBITA-2 trial

Session: The year in review: top trials in coronary interventions impacting guidelines and patient care

Topic: Percutaneous Coronary Intervention (PCI)

Speaker: Doctor R. Al-Lamee (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rasha Al-Lamee

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

23 presentations

6 followers

4 more presentations in this session

Microaxial flow pump or standard care in infarct-related cardiogenic shock: the DanGer shock trial

Speaker: Professor C. Hassager (Copenhagen, DK)

ILUMIEN IV: optical coherence tomography-guided vs. angiography-guided PCI

Speaker: Doctor Z. Ali (New York, US)

Paclitaxel-coated balloon vs. uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomised clinical trial

Speaker: Doctor R. Yeh (Boston, US)

The year in review: top trials in coronary interventions impacting guidelines and patient care - discussion

Access the full session

The year in review: top trials in coronary interventions impacting guidelines and patient care

Speakers: Doctor R. Al-Lamee, Professor C. Hassager, Doctor Z. Ali, Doctor R. Yeh

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources